The measurement of R2, R2 and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition

Magnetic Resonance Imaging

Volumn 15, Issue 10, 1997, Pages 1113-1119

  Miszkiel, K A ^a   Paley, M N J ^a   Wilkinson, I D ^a   Hall Craggs, M A ^a   Ordidge, R ^a   Kendall, B E ^a   Miller, R F ^a   Harrison, M J G ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Brain iron deposition; Caudate nucleus; Globus pallidus; HIV infected; PRIME sequence

Indexed keywords

IRON;

ADULT; ARTICLE; BASAL GANGLION; BRAIN DISEASE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON STORAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; METABOLISM; PATHOLOGY;

ADULT; AIDS DEMENTIA COMPLEX; BASAL GANGLIA; BRAIN; CAUDATE NUCLEUS; CD4 LYMPHOCYTE COUNT; FEMALE; GLOBUS PALLIDUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0031299381     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00089-1     Document Type: Article

References (40)

1. 1. Hallgren, B.; Sourander, P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3:41-51; 1958.
2. 2. Diezel, P.B. Iron in the brain: A clinical and histochemical examination. In: H. Waelsch (Ed). Biochemistry of the Developing Nervous System. New York: Academic Press, 1955: pp. 145-152.
3. 3. Hill, J.M. The distribution of iron in the brain. In: M.B.H. Youdim (Ed). Brain Iron: Neurochemical and Behavioural Aspects. London: Taylor and Francis, Philadelphia, 1988: pp. 1-24.
4. 4. Drayer, B.; Burger, P.; Darwin, R.; Riederer, S.; Herfkens, R.; Johnson, G.A. MRI of brain iron. AJR 147:103-110; 1982.
5. 5. Seitelberger, F. Pigmentary disorders. In: J. Minckler (Ed): Pathology of the Nervous System. New York Blakiston Division: McGraw Hill, 1997:1324-1338.
6. 6. Park, B.E.; Netsky, M.G.; Betsill, W.L. Pathogenesis of pigment and spheroid formation in Hallervordan-Spatz syndrome and related disorders. Neurology 25:1172-1178; 1975.
7. 7. Jankovic, J.; Kirkpatrick, J.B.; Blomquist, K.A.; Langlaid, P.J.; Bird, E.D. Late onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology 35:227-234; 1985.
8. 8. Klintworth, G.K. Huntington's chorea-morphologic contributions of a century. In: A. Barbeau, T. N. Chase, G. W. Paulson (Eds). Advances in Neurology, Vol. 1. New York: Raven Press; 1973: pp. 353-368.
9. 9. Rojas, G.; Asenjo, A.; Chiorino, R.; Arunda, L.; Rocamora, R.; Dorioso, P. Cellular and subcellular structure of the ventrolateral nucleus of the thalamus in Parkinson's disease. Deposits of iron. Confin. Neurol. 26:362-376; 1965.
10. 10. Hallgren, B.; Sourander, P. The non-haemin iron in the cerebral cortex in Alzheimer's disease. J. Neurochem. 5: 307-310; 1960.
11. 11. Bartozkis, G.; Sultzer, D.; Mintz, J.; Holt, L.E.; Marx, P.; Phelan, C.K.; Marder, S.R. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 35:480-487; 1994.
12. 12. Smith, T.W.; De Girolami, U.; Henin, D.; Bolgert, F.; Hauw, J.-J. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 40:357-370; 1990.
13. 13. De Girolami, U.; Smith, T.W.; Henin, D.; Hauw, J.-J. Neuropathology of the acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 114:643-655; 1990.
14. 14. Gelman, B.B.; Rodriguez-Wolf, M.G.; Wen, J.; Kumar, S.; Campbell, G.R.; Herzog, N. Siderotic cerebral macrophages in the acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 116:509-516; 1992.
15. 15. Antonini, A.; Leenders, K.L.; Meier, D.; Oertel, W.H.; Boesiger, P.; Anliker, M. T2 relaxation time in patients with Parkinson's disease. Neurology 43:697-700; 1993.
16. 16. Rutledge, J.N.; Hilal, S.K.; Silver, A.J.; Defendini, R.; Fahn, S. Study of movement disorders and brain iron by MR. AJNR 8:397-411; 1987.
17. 17. Braffman, B.H.; Grossman, R.I.; Goldberg, H.I.; Stern, M.B.; Hurtig, H.I.; Hackney, D.B.; Bilaniuk, I.T.; Zimmerman, R.A. MR imaging of Parkinson's disease with spin-echo and gradient-echo sequences. AJNR 152:159-165; 1989.
18. 18. Chen, J.C.; Hardy, P.; Clauberg, M.; Joshi, J.G.; Parravano, J.; Deck, H.N.; Henkelman, R.M.; Becker, L.E.; Kucharczyk, W. T2 values in the human brain: Comparison with quantitative assays of iron and ferritin. Radiology 173:521-526; 1989.
19. 19. Brooks, D.J.; Luthert, P.; Gadian, D.; Marsden, D. Does signal attenuation on high field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. J. Neurol. Neurosurg. Psychiatr. 52:108-111; 1989.
20. 20. Ordidge, R.; Gorrell, J.M.; Deniau, J.C.; Knight, R.A.; Helpern, J.A. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Mag. Reson. Med. 32:335-341; 1994.
21. 21. CDC. Revision of the CDC surveillance case definitions for acquired immunodeficiency syndrome. U.S. Morbid. Mortal. Wkly Rpt. 36 (suppl 1S):1S-15S; 1987.
22. 22. Wilkinson, I.D.; Paley, M.N.J.; Hall-Craggs, M.A.; Chinn, R.S.J.; Chong, W.K.; Sweeney, B.J.; Kendall, B.E.; Miller, R.F.; Newman, S.P.; Harrison, M.J.G. Cerebral magnetic resonance relaxometry in HIV infection. Magn. Reson. Imaging 14(3):365-372; 1996.
23. 23. Kang C. A comparison of techniques in the assessment of bone density and structure in the calcaneus. Ph.D. Dissertation. London, England: University of London; 1997.
24. 24. Gupta, S.; Imam, A.; Licorish, K. Serum ferritin in acquired immunodeficiency syndrome. J. Clin. Lab. Immunol. 20:11-13; 1986.
25. 25. Blumberg, B.S.; Hann, H.W.L.; Mildvan, D.; Mathur, U.; Lustbader, E.; London, W.T. Iron and iron binding proteins in persistent generalised lymphadenopathy and AIDS. Lancet 1:347; 1984.
26. 26. Weinberg, E.D. Iron withholding: A defence against infection and neoplasia. Physiol. Rev. 64:65-102; 1984.
27. 27. Morris, C.D.; Bird, A.R.; Nell, H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q. J. Med. 73:1151-1159; 1989.
28. 28. Drayer, B.P.; Olanow, W.; Burger, P.; Johnson, G.A.; Herfkens, R.; Riederer, S. Parkinson's plus syndrome: Diagnosis using high MR imaging of brain iron. Radiology 159:493-498; 1986.
29. 29. Hill, J.M.; Switzer, R.C. III. The regional distribution and cellular localization of iron in rat brain. Neurosciences 11:595-603; 1984.
30. 30. Mackler, B.; Parson, R.; Miller, L.R.; Inamdar, A.R.; Finch, O.A. Iron deficiency in the rat. Biochemical studies of brain metabolism. Paediatr. Res. 12:217-224; 1978.
31. 31. Youdim, M.B.H.; Green, A.R.; Bloomfield, M.R.; Mitchell, B.D.; Heal, D.J.; Graham-Smith, D.G. The effects of iron deficiency on brain biogenic monoamine biochemistry function in rats. Neuropharmacology 19:259-267; 1980.
32. 32. Youdim, M.B.H.; Yehuda, S.; Ben-Shachar, D.; Ashkenazi, R. Behavioural and brain biochemical changes in iron deficient rats: The involvement of iron and dopamine receptor function. In: E. Pollitt, R.L. Leibel (Eds). Iron Deficiency: Brain Biochemistry and Behaviour. New York: Raven Press, 1982: pp. 39-56.
33. 33. Ben-Shachar, D.; Finberg, J.P.M.; Youdim, M.B.H. Effect of iron chelators on dopamine D2 receptors. J. Neurochem. 45:999-1005; 1985.
34. 34. Fahn, S. Regional distribution studies of GABA and other putative neurotransmitters and their enzymes. In: E. Roberts, T.N. Chase, D.B. Tower (Eds). GABA and Nervous System Function. New York: Raven Press, 1976: pp. 169-186.
35. 35. Gutteridge, J.M.C.; Richmond, R.; Halliwel, B. Inhibition of the iron-catalyzed formation of hydroxy radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem. J. 84:469-472; 1990.
36. 36. Navia, B.A.; Jordan, B.D.; Price, R.W. The AIDS dementia complex: Clinical features. Ann. Neurol. 19:517-524; 1986.
37. 37. Metzer, W.S. Movement disorders with AIDS encephalopathy: Case report. Neurology 37:1438; 1987.
38. 38. Factor, S.A.; Podskalny, G.D.; Barron, K.D. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. J. Neurol. Sci. 127:114-120; 1994.
39. 39. Arendt, G.; Hefter, H.; Elsing, C; Strohmeyer, G.; Freund, H.J. Motor dysfunction in HIV-infected patients without clinically detectable central nervous deficit. J. Neurol. 237: 362-368; 1990.
40. 40. Reyes, M.G.; Faraldi, F.; Senseng, C.S.; Flowers, C.; Fariello, R. Nigral degeneration in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol. 82:39-44; 1991.